Amneal Pharmaceuticals, Inc. (FRA:2DT)

Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,869	2,370	1,683	282	629	552
Market Cap Growth	63.02%	40.80%	496.83%	-55.17%	14.07%	-4.24%
Enterprise Value	6,033	4,908	4,011	2,796	2,965	2,837
Last Close Price	12.10	7.35	5.45	1.83	4.26	3.61
PE Ratio	769.41	-	-	-	67.35	7.41
PS Ratio	1.55	0.88	0.78	0.14	0.34	0.34
PB Ratio	-107.64	-55.10	30.35	1.44	1.86	1.89
P/FCF Ratio	18.19	10.45	6.23	18.49	3.75	2.13
P/OCF Ratio	13.85	8.32	5.38	4.63	2.96	1.78
EV/Sales Ratio	2.42	1.82	1.85	1.35	1.61	1.74
EV/EBITDA Ratio	11.03	8.69	8.85	6.79	7.49	9.11
EV/EBIT Ratio	18.54	14.59	16.34	14.94	15.57	23.83
EV/FCF Ratio	28.36	21.64	14.84	183.29	17.67	10.94
Debt / Equity Ratio	-63.68	-58.22	44.87	13.62	7.52	8.41
Debt / EBITDA Ratio	4.17	4.28	5.26	6.15	6.15	7.36
Debt / FCF Ratio	10.76	11.05	9.21	174.50	15.13	9.46
Net Debt / Equity Ratio	-58.86	-55.70	43.34	13.49	6.87	7.45
Net Debt / EBITDA Ratio	3.98	4.24	5.31	6.40	5.86	6.97
Net Debt / FCF Ratio	9.94	10.57	8.89	172.79	13.82	8.37
Asset Turnover	0.83	0.80	0.66	0.57	0.53	0.52
Inventory Turnover	3.04	2.98	2.75	2.79	2.67	3.08
Quick Ratio	1.31	0.82	0.87	1.10	1.39	1.49
Current Ratio	2.13	1.41	1.63	1.88	2.25	2.29
Return on Equity (ROE)	-	-881.26%	-36.06%	-85.96%	5.45%	19.50%
Return on Assets (ROA)	6.79%	6.24%	4.67%	3.23%	3.41%	2.37%
Return on Invested Capital (ROIC)	13.13%	13.52%	9.45%	6.61%	4.62%	4.87%
Return on Capital Employed (ROCE)	14.00%	14.70%	10.30%	6.60%	6.60%	4.40%
Earnings Yield	0.13%	-4.76%	-4.51%	-43.12%	1.49%	13.50%
FCF Yield	5.50%	9.57%	16.06%	5.41%	26.68%	47.01%
Buyback Yield / Dilution	-9.44%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%
Total Shareholder Return	-9.44%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.